From Ancient Recipes to Timed Systems: The Origins of Controlled Release

0:00Welcome to Creative Biolapse's podcast channel. Join us as we explore the cutting-edge science of targeted delivery systems that are revolutionizing medicine. Interested in the future of drug development? Subscribe now. Welcome back to the Pharma Frontier, the podcast where we explore the cutting edge of medicine delivery. I'm your host, Alex. Today, we're starting a fascinating three-part journey into the evolution of how we deliver drugs. We're not just talking about pills and injections, but about smart systems that can release medicine at the right time in the right place for the right duration. It's the story of controlled drug delivery. And to guide us through this rich history in science, I'm thrilled to have with us Dr. Lena Cruz, a renowned expert in pharmaceutical sciences. Welcome, Dr. Cruz. Thank you, Alex. It's a pleasure to be here. The story of controlled delivery is indeed a remarkable one weaving together ancient wisdom, modern pharmacology, and material engineering.

1:03Let's start at the very beginning. When we think of advanced drug delivery, it feels very modern. But the book suggests the idea has much older roots. Absolutely. The desire to control how a medicine works in the body is ancient. For instance, a Chinese text from around 168 BC called Recipes for 52 ailments, mentions using animal fats and preparations, likely to prolong the action of the medicine. Greek and Roman physicians like dio scourides and Galen were masters of formulating mixtures from natural sources. So, the concept of a dosage form, something more than just a raw herb, is very old. But the modern scientific concept of controlled release really began to crystallize in the mid 20th century. What was the key shift that moved us from traditional mixtures to these controlled systems? The big leap forward came with the formal understanding of biopharmaceuticals and pharmacokinetics, essentially the science of what the body does to a drug.

2:06Before the 1960s, we knew a drug worked, but tracking its precise journey, how it's absorbed, distributed, metabolized, and excreted over time, was not a precise science. Pioneering scientists like Wagner, Nelson, and Regulman developed the mathematical models to describe this. This was a game changer. Why was that so revolutionary? Can you give us a simple example? Of course. Think of a common painkiller like ibuprofen. You take a pill, it dissolves, and the drug level in your blood shoots up quickly, giving you relief. But then your liver and kidney start to clear it. The drug level falls. In a few hours, it might drop below the level needed to stop the pain. So you have to take another pill. That up and down cycle is what pharmacokinetics maps out. The half-life tells you how fast that drop happens. So the goal became to smooth out that roller coaster ride?

3:08Exactly. The goal became to maintain the drug concentration in a therapeutic window above the minimum level to be effective, but below the level that causes toxic side effects for as long as possible. This understanding is why we have every 12 hour or once a day extended release pills. They are designed based on the drug's pharmacokinetic profile. That makes so much sense. It's not just about convenience, it's about safety and steady therapy. Precisely. For chronic conditions like high blood pressure or epilepsy, maintaining a steady state is critical to prevent symptoms or dangerous events. This science gave birth to the first modern controlled release products. A landmark early success was the Spansell technology by Smith Klein and French in 1952 for a drug called Dexadrine. How did the Spansell work? It was ingeniously simple. They coated tiny drug beads with wax of different thicknesses.

4:10The thin coatings dissolved quickly for an immediate effect while the thicker coatings dissolved later, providing sustained release. This was a major commercial success and proved the concept that you could package multiple release timings into a single capsule. That's clever. But I understand a pivotal moment was the founding of a specific company dedicated to this idea. Yes, that was ALZA Corporation, founded in 1968 by Alejandro Zafaroni. ALZA was built on the vision of control delivery as a discipline itself. They moved beyond simple coatings to sophisticated systems based on engineering principles. One of their first major products was the Ocusert in 1974, an ocular insert for glaucoma. And insert for the eye? That sounds delicate. It was. It was a tiny flexible membrane placed under the eyelid that released pylocarpine at a constant, zero-order rate for a week.

5:11This was a huge improvement over eye drops, which patients often forget to use and which cause a spike and drop in drug levels. The Ocusert provided constant, precise dosing. And the idea of implants also took off around this time? Correct. Judah Folkman, famous for his work on tumors, was also a pioneer here. He showed drugs could be steadily released from silicone capsules. Then, in 1983, the Population Council introduced Norplant, a contraceptive implant. It consisted of six small silicone rods placed under the skin, releasing a hormone steadily for five years. This showed the potential for truly long-term, patient-compliant therapy without relying on daily or weekly action. The 1980s also brought us the transdermal patch, right? Indeed. Zaferoni himself patented the concept of a bandage for administering drugs in the early 1970s.

6:11The first commercial patch, Scopiderm for motion sickness, came to market in 1979. It delivered Scopolamine through the skin, bypassing the stomach and providing steady relief for days. This opened the door for patches for angina, smoking cessation, pain management, and more. So patches use the skin as the delivery route. And we can't forget the oral route. Pills are still the most common way we take medicine. Did controlled release of all there too? Of course. After Matrix tablets were patented in the 1960s, ALZ developed one of the most elegant oral systems, the oral osmotic pump, or OOS, based on a patent by Thouis and Higuchi. Osmotic pump? That sounds like it uses water pressure. You're exactly right. Think of it like a tiny, sophisticated pump in a pill. It has a semi-permeable membrane. Water from your gut enters the pill and dissolves the salt core, creating osmotic pressure.

7:16That pressure pushes a drug solution out through a laser drilled hole at a constant rate. The first big OOS product was Procardia XL for high blood pressure in 1989. It was a major achievement in precise oral delivery. So, by the late 1980s, the field had moved from a scientific idea to approve and technology with products in the clinic for eyes, skin, implants, and oral use. That's an incredible foundation. Precisely. The foundation was solid. Pharmacokinetics told us why we needed control, and early engineering showed us how to achieve it with polymers and simple physical principles. But this was just the beginning. The next wave of evolution would be driven by two things, the creation of amazing new materials and the daunting challenge of delivering a whole new class of drugs, giant molecules like proteins and genes. That sounds like the perfect place for us to pick up next time. Dr. Cruz, thank you for this fantastic overview of the origins of controlled release.

8:20My pleasure, Alex. Join us next week on the Farm of Frontier, where we'll dive into the materials revolution and the puzzle of delivering biological drugs. Until then, stay curious.